Generation of a New Humanized Pompe Disease Model for Improved Robust // Pre-Clinical Evaluation of new Pompe Therapeutics
Untargeted breathomics identifies metabolic signatures of immune activity, intestinal integrity, and fatigue in systemic lupus erythematosus.Autores: Parodis I, Iacubino M, Rocco L, Nikolopoulos D, Palazzo L, Grimmett L, Kerr M, Bellocchi C, Vigone B, Santaniello A, Barturen G, Voskuyl AE, Alarcón-Riquelme ME, Beretta L01/2026 - Annals of the rheumatic diseases
Functional in vitro assessment of the HER2 Ile655Val variant on trastuzumab-induced cardiotoxicity in human cardiomyocytes.Autores: Pozo-Agundo A, García-Rodríguez S, Antúnez-Rodríguez A, Chica-Redecillas L, Cejas RB, Lyra-Leite D, Porras-Quesada P, Gómez-Sánchez J, Mirón-Pozo B, Álvarez-Cubero MJ, Burridge PW, Martin F, Martínez-González LJ, Dávila-Fajardo CL01/2026 - European journal of pharmacology
Corrigendum to "International expert consensus on the clinical integration of circulating tumor cells in solid tumors" [Eur. J. Cancer 231 (2025) 116050].Autores: Nicolò E, Reduzzi C, Pierga JY, Gazzaniga P, Stoecklein NH, Denninghoff V, Rothwell DG, De Bono JS, Marchetti D, Lianidou E, Riethdorf S, Generali D, Hofman P, Gerratana L, Kuhn P, Thiery JP, Ignatiadis M, Bidard FC, Lucci A, Kasimir-Bauer S, Serrano MJ, Cristofanilli M01/2026 - European journal of cancer (Oxford, England : 1990)
